(Q33733181)

29 July 2017

title

Analysis of the clinical benefit of 5-fluorouracil and radiation treatment in locally advanced pancreatic cancer (English)

1 reference

29 July 2017

1 reference

1 reference

Fisher BJ

1

1 reference

29 July 2017

Perera FE

2

1 reference

29 July 2017

Kocha W

3

1 reference

29 July 2017

Tomiak A

4

1 reference

29 July 2017

Taylor M

5

1 reference

29 July 2017

Vincent M

6

1 reference

29 July 2017

Bauman GS

7

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 September 1999

1 reference

International Journal of Radiation Oncology Biology Physics

29 July 2017

published in

1 reference

29 July 2017

volume

45

1 reference

29 July 2017

issue

2

1 reference

29 July 2017

page(s)

291-295

1 reference

Epidemiology of pancreatic cancer

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

The National Cancer Data Base report on pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

No standard treatment is available for advanced pancreatic cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

Radiation therapy combined with Adriamycin or 5-fluorouracil for the treatment of locally unresectable pancreatic carcinoma. Gastrointestinal Tumor Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

Phase II trial of gemcitabine (2,2'-difluorodeoxycytidine) in patients with adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2899%2900197-2

7 January 2021

10.1016/S0360-3016(99)00197-2

Identifiers

DOI

1 reference

29 July 2017

1 reference